|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer Genome Atlas Research Network:
Albert Einstein College of Medicine; Analytical Biological
Services; Barretos Cancer Hospital; Baylor College of Medicine;
Beckman Research Institute of City of Hope; Buck Institute for
Research on Aging; Canada's Michael Smith Genome Sciences Centre;
Harvard Medical School, . Helen F, et al: Integrated genomic and
molecular characterization of cervical cancer. Nature. 543:378–384.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tewari KS and Monk BJ: Gynecologic
oncology group trials of chemotherapy for metastatic and recurrent
cervical cancer. Curr Oncol Rep. 7:419–434. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liontos M, Kyriazoglou A, Dimitriadis I,
Dimopoulos MA and Bamias A: Systemic therapy in cervical cancer: 30
Years in review. Crit Rev Oncol Hematol. 137:9–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mutlu L, Tymon-Rosario J, Harold J and
Menderes G: Targeted treatment options for the management of
metastatic/persistent and recurrent cervical cancer. Expert Rev
Anticancer Ther. 22:633–645. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li C, Teixeira AF, Zhu HJ and ten Dijke P:
Cancer associated-fibroblast-derived exosomes in cancer
progression. Mol Cancer. 20:1542021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Liu L, Yao HH, Zhu ZQ, Ning ZL and
Huang Q: Stromal myofibroblasts are associated with poor prognosis
in solid cancers: A meta-analysis of published studies. PLoS One.
11:e01599472016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lavie D, Ben Shmuel A, Erez N and Scherz
Shouval R: Cancer-associated fibroblasts in the single-cell era.
Nat Cancer. 3:793–807. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan Y, Cai X, Shen F and Ma F: HPV
post-infection microenvironment and cervical cancer. Cancer Lett.
497:243–254. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wright JD, Matsuo K, Huang Y, Tergas AI,
Hou JY, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI and
Hershman DL: Prognostic performance of the 2018 international
federation of gynecology and obstetrics cervical cancer staging
guidelines. Obstet Gynecol. 134:49–57. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garré JM, Silva HM, Lafaille JJ and Yang
G: CX3CR1+ monocytes modulate learning and
learning-dependent dendritic spine remodeling via TNF-α. Nat Med.
23:714–722. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Y, Chen S, Li K, Zhang Y, Huang X, Li
T, Wu S, Wang Y, Carey LB and Qian W: Overdosage of balanced
protein complexes reduces proliferation rate in aneuploid cells.
Cell Syst. 9:129–142.e5. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Diskin B, Adam S, Cassini MF, Sanchez G,
Liria M, Aykut B, Buttar C, Li E, Sundberg B, Salas RD, et al:
PD-L1 engagement on T cells promotes self-tolerance and suppression
of neighboring macrophages and effector T cells in cancer. Nat
Immunol. 21:442–454. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cano Gamez E, Soskic B, Roumeliotis TI, So
E, Smyth DJ, Baldrighi M, Willé D, Nakic N, Esparza Gordillo J,
Larminie CGC, et al: Single-cell transcriptomics identifies an
effectorness gradient shaping the response of CD4+ T
cells to cytokines. Nat Commun. 11:18012020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xin Z, Lin M, Hao Z, Chen D, Chen Y, Chen
X, Xu X, Li J, Wu D, Chai Y and Wu P: The immune landscape of human
thymic epithelial tumors. Nat Commun. 13:54632022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang C, Siebert JR, Burns R, Gerbec ZJ,
Bonacci B, Rymaszewski A, Rau M, Riese MJ, Rao S, Carlson KS, et
al: Heterogeneity of human bone marrow and blood natural killer
cells defined by single-cell transcriptome. Nat Commun.
10:39312019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Deng Y, Zheng Y, Li D, Hong Q, Zhang M, Li
Q, Fu B, Wu L, Wang X, Shen W, et al: Expression characteristics of
interferon-stimulated genes and possible regulatory mechanisms in
lupus patients using transcriptomics analyses. EBioMedicine.
70:1034772021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Z, Zhou L, Liu L, Hou Y, Xiong M,
Yang Y, Hu J and Chen K: Single-cell RNA sequencing highlights the
role of inflammatory cancer-associated fibroblasts in bladder
urothelial carcinoma. Nat Commun. 11:50772020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He D, Wang D, Lu P, Yang N, Xue Z, Zhu X,
Zhang P and Fan G: Single-cell RNA sequencing reveals heterogeneous
tumor and immune cell populations in early-stage lung
adenocarcinomas harboring EGFR mutations. Oncogene. 40:355–368.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wagner J, Rapsomaniki MA, Chevrier S,
Anzeneder T, Langwieder C, Dykgers A, Rees M, Ramaswamy A, Muenst
S, Soysal SD, et al: A single-cell atlas of the tumor and immune
ecosystem of human breast cancer. Cell. 177:1330–1345.e18. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng H, Liu H, Ge Y and Wang X:
Integrated single-cell and bulk RNA sequencing analysis identifies
a cancer associated fibroblast-related signature for predicting
prognosis and therapeutic responses in colorectal cancer. Cancer
Cell Int. 21:5522021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liberzon A, Birger C, Thorvaldsdóttir H,
Ghandi M, Mesirov JP and Tamayo P: The molecular signatures
database (MSigDB) hallmark gene set collection. Cell Syst.
1:417–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sergushichev AA: An algorithm for fast
preranked gene set enrichment analysis using cumulative statistic
calculation. bioRxiv. 0600122016.
|
|
24
|
Wang Z, Li Z, Zhou K, Wang C, Jiang L,
Zhang L, Yang Y, Luo W, Qiao W, Wang G, et al: Deciphering cell
lineage specification of human lung adenocarcinoma with single-cell
RNA sequencing. Nat Commun. 12:65002021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goldman MJ, Craft B, Hastie M, Repečka K,
McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al:
Visualizing and interpreting cancer genomics data via the Xena
platform. Nat Biotechnol. 38:675–678. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee YY, Kim TJ, Kim JY, Choi CH, Do IG,
Song SY, Sohn I, Jung SH, Bae DS, Lee JW and Kim BG: Genetic
profiling to predict recurrence of early cervical cancer. Gynecol
Oncol. 131:650–654. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Simon N, Friedman J, Hastie T and
Tibshirani R: Regularization paths for Cox's proportional hazards
model via coordinate descent. J Stat Softw. 39:1–13. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan Y, Zhang M and Xu S and Xu S:
Identification of an immune gene expression signature for
predicting lung squamous cell carcinoma prognosis. Biomed Res Int.
2020:50249422020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gong Z, Hong F, Wang H, Zhang X and Chen
J: An eight-mRNA signature outperforms the lncRNA-based signature
in predicting prognosis of patients with glioblastoma. BMC Med
Genet. 21:562020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang X, Wu W, Pan Y, Zhou Q, Xu J and Han
S: Immune-related genes in tumor-specific CD4+ and
CD8+ T cells in colon cancer. BMC Cancer. 20:5852020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hänzelmann S, Castelo R and Guinney J:
GSVA: Gene set variation analysis for microarray and RNA-seq data.
BMC Bioinformatics. 14:72013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang D, Zhang Y, Wang X, Zhang L and Xu S:
Construction and validation of an aging-related gene signature
predicting the prognosis of pancreatic cancer. Front Genet.
14:10222652023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X,
Li Z, Traugh N, Bu X, Li B, et al: Signatures of T cell dysfunction
and exclusion predict cancer immunotherapy response. Nat Med.
24:1550–1558. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arina A, Idel C, Hyjek EM, Alegre ML, Wang
Y, Bindokas VP, Weichselbaum RR and Schreiber H: Tumor-associated
fibroblasts predominantly come from local and not circulating
precursors. Proc Natl Acad Sci USA. 113:7551–7556. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang W, Soares J, Greninger P, Edelman EJ,
Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, et
al: Genomics of drug sensitivity in cancer (GDSC): A resource for
therapeutic biomarker discovery in cancer cells. Nucleic Acids Res.
41:(Database Issue). D955–D961. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maeser D, Gruener RF and Huang RS:
oncoPredict: An R package for predicting in vivo or cancer patient
drug response and biomarkers from cell line screening data. Brief
Bioinform. 22:bbab2602021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Y, Lu S, Lan M, Peng X, Zhang Z and
Lang J: A prognostic nomogram integrating novel biomarkers
identified by machine learning for cervical squamous cell
carcinoma. J Transl Med. 18:2232020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Long J, Chen P, Lin J, Bai Y, Yang X, Bian
J, Lin Y, Wang D, Yang X, Zheng Y, et al: DNA methylation-driven
genes for constructing diagnostic, prognostic, and recurrence
models for hepatocellular carcinoma. Theranostics. 9:7251–7267.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Song K, Hao J, Ge Z and Chen P: Clinical
and survival impact of sex-determining region Y-Box 2 in colorectal
cancer: An integrated analysis of the immunohistochemical study and
bioinformatics analysis. J Oncol. 2020:37615352020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yoshida GJ: Regulation of heterogeneous
cancer-associated fibroblasts: The molecular pathology of activated
signaling pathways. J Exp Clin Cancer Res. 39:1122020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Au Yeung CL, Tsang TY, Yau PL and Kwok TT:
Human papillomavirus type 16 E6 induces cervical cancer cell
migration through the p53/microRNA-23b/urokinase-type plasminogen
activator pathway. Oncogene. 30:2401–2410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sato T, Sakai T, Noguchi Y, Takita M,
Hirakawa S and Ito A: Tumor-stromal cell contact promotes invasion
of human uterine cervical carcinoma cells by augmenting the
expression and activation of stromal matrix metalloproteinases.
Gynecol Oncol. 92:47–56. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang W, Ge Y, Cheng Q, Zhang Q, Fang L
and Zheng J: Decorin is a pivotal effector in the extracellular
matrix and tumour microenvironment. Oncotarget. 9:5480–5491. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schulz WA, Ingenwerth M, Djuidje CE, Hader
C, Rahnenführer J and Engers R: Changes in cortical cytoskeletal
and extracellular matrix gene expression in prostate cancer are
related to oncogenic ERG deregulation. BMC Cancer. 10:5052010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lucarelli G, Rutigliano M, Bettocchi C,
Palazzo S, Vavallo A, Galleggiante V, Trabucco S, Di Clemente D,
Selvaggi FP, Battaglia M and Ditonno P: Spondin-2, a secreted
extracellular matrix protein, is a novel diagnostic biomarker for
prostate cancer. J Urol. 190:2271–2277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kubala JM, Laursen KB, Schreiner R,
Williams RM, van der Mijn JC, Crowley MJ, Mongan NP, Nanus DM,
Heller DA and Gudas LJ: NDUFA4L2 reduces mitochondrial respiration
resulting in defective lysosomal trafficking in clear cell renal
cell carcinoma. Cancer Biol Ther. 24:21706692023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen PH, Shen WL, Shih CM, Ho KH, Cheng
CH, Lin CW, Lee CC, Liu AJ and Chen KC: The CHAC1-inhibited Notch3
pathway is involved in temozolomide-induced glioma cytotoxicity.
Neuropharmacology. 116:300–314. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Deaton RA, Bulut G, Serbulea V, Salamon A,
Shankman LS, Nguyen AT and Owens GK: A new autosomal
Myh11-CreERT2 smooth muscle cell lineage tracing and
gene knockout mouse model-brief report. Arterioscler Thromb Vasc
Biol. 43:203–211. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Loumaye A, Lause P, Zhong X, Zimmers TA,
Bindels LB and Thissen JP: Activin a causes muscle atrophy through
MEF2C-dependent impaired myogenesis. Cells. 11:11192022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yoshihara K, Shahmoradgoli M, Martínez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chiossone L, Dumas PY, Vienne M and Vivier
E: Natural killer cells and other innate lymphoid cells in cancer.
Nat Rev Immunol. 18:671–688. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Giles JR, Globig AM, Kaech SM and Wherry
EJ: CD8+ T cells in the cancer-immunity cycle. Immunity.
56:2231–2253. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Speiser DE, Chijioke O, Schaeuble K and
Münz C: CD4+ T cells in cancer. Nat Cancer. 4:317–329.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wei E, Reisinger A, Li J, French LE,
Clanner-Engelshofen B and Reinholz M: Integration of scRNA-Seq and
TCGA RNA-Seq to analyze the heterogeneity of HPV+ and HPV-cervical
cancer immune cells and establish molecular risk models. Front
Oncol. 12:8609002022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Johnson DE, Burtness B, Leemans CR, Lui
VWY, Bauman JE and Grandis JR: Head and neck squamous cell
carcinoma. Nat Rev Dis Primers. 6:922020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shaker OG, Hammam OA and Wishahi MM: Is
there a correlation between HPV and urinary bladder carcinoma?
Biomed Pharmacother. 67:183–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Pelizzer T, Dias CP, Poeta J, Torriani T
and Roncada C: Colorectal cancer prevalence linked to human
papillomavirus: A systematic review with meta-analysis. Rev Bras
Epidemiol. 19:791–802. 2016.(In Portuguese, English). View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chen AC, Waterboer T, Keleher A, Morrison
B, Jindal S, McMillan D, Nicol D, Gardiner RA, McMillan NA and
Antonsson A: Human papillomavirus in benign prostatic hyperplasia
and prostatic adenocarcinoma patients. Pathol Oncol Res.
17:613–617. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kamat AM, Hahn NM, Efstathiou JA, Lerner
SP, Malmström PU, Choi W, Guo CC, Lotan Y and Kassouf W: Bladder
cancer. Lancet. 388:2796–2810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Gelibter AJ, Caponnetto S, Urbano F,
Emiliani A, Scagnoli S, Sirgiovanni G, Napoli VM and Cortesi E:
Adjuvant chemotherapy in resected colon cancer: When, how and how
long? Surg Oncol. 30:100–107. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Schatten H: Brief overview of prostate
cancer statistics, grading, diagnosis and treatment strategies. Adv
Exp Med Biol. 1095:1–14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Shanmugaraj B, Malla A, Bulaon CJI,
Phoolcharoen W and Phoolcharoen N: Harnessing the potential of
plant expression system towards the production of vaccines for the
prevention of human papillomavirus and cervical cancer. Vaccines
(Basel). 10:20642022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
National Comprehensive Cancer Network and
Clinical practice guidelines in oncology cervical cancer, . version
4. 2019. https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdfMarch
29–2019.
|
|
65
|
Mauricio D, Zeybek B, Tymon-Rosario J,
Harold J and Santin AD: Immunotherapy in cervical cancer. Curr
Oncol Rep. 23:612021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Long HJ III, Bundy BN, Grendys EC Jr,
Benda JA, McMeekin DS, Sorosky J, Miller DS, Eaton LA and Fiorica
JV; Gynecologic Oncology Group Study, : Randomized phase III trial
of cisplatin with or without topotecan in carcinoma of the uterine
cervix: A gynecologic oncology group study. J Clin Oncol.
23:4626–4633. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Monk BJ, Sill MW, McMeekin DS, Cohn DE,
Ramondetta LM, Boardman CH, Benda J and Cella D: Phase III trial of
four cisplatin-containing doublet combinations in stage IVB,
recurrent, or persistent cervical carcinoma: A gynecologic oncology
group study. J Clin Oncol. 27:4649–4655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Chen Y, McAndrews KM and Kalluri R:
Clinical and therapeutic relevance of cancer-associated
fibroblasts. Nat Rev Clin Oncol. 18:792–804. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Szymonowicz KA and Chen J: Biological and
clinical aspects of HPV-related cancers. Cancer Biol Med.
17:864–878. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Spurgeon ME and Lambert PF: Human
papillomavirus and the stroma: Bidirectional crosstalk during the
virus life cycle and carcinogenesis. Viruses. 9:2192017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Fullár A, Dudás J, Oláh L, Hollósi P, Papp
Z, Sobel G, Karászi K, Paku S, Baghy K and Kovalszky I: Remodeling
of extracellular matrix by normal and tumor-associated fibroblasts
promotes cervical cancer progression. BMC Cancer. 15:2562015.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Pilch H, Schlenger K, Steiner E,
Brockerhoff P, Knapstein P and Vaupel P: Hypoxia-stimulated
expression of angiogenic growth factors in cervical cancer cells
and cervical cancer-derived fibroblasts. Int J Gynecol Cancer.
11:137–142. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Woodby B, Scott M and Bodily J: The
interaction between human papillomaviruses and the stromal
microenvironment. Prog Mol Biol Transl Sci. 144:169–238. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Murata T, Mizushima H, Chinen I, Moribe H,
Yagi S, Hoffman RM, Kimura T, Yoshino K, Ueda Y, Enomoto T and
Mekada E: HB-EGF and PDGF mediate reciprocal interactions of
carcinoma cells with cancer-associated fibroblasts to support
progression of uterine cervical cancers. Cancer Res. 71:6633–6642.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Chiantore MV, Mangino G, Iuliano M,
Zangrillo MS, De Lillis I, Vaccari G, Accardi R, Tommasino M,
Columba Cabezas S, Federico M, et al: Human papillomavirus E6 and
E7 oncoproteins affect the expression of cancer-related microRNAs:
Additional evidence in HPV induced tumorigenesis. J Cancer Res Clin
Oncol. 142:1751–1763. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Evanko SP, Potter-Perigo S, Bollyky PL,
Nepom GT and Wight TN: Hyaluronan and versican in the control of
human T-lymphocyte adhesion and migration. Matrix Biol. 31:90–100.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bougherara H, Mansuet-Lupo A, Alifano M,
Ngô C, Damotte D, Le Frère-Belda MA, Donnadieu E and Peranzoni E:
Real-time imaging of resident T cells in human lung and ovarian
carcinomas reveals how different tumor microenvironments control T
lymphocyte migration. Front Immunol. 6:5002015. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Grindel BJ, Martinez JR, Tellman TV,
Harrington DA, Zafar H, Nakhleh L, Chung LW and Farach Carson MC:
Matrilysin/MMP-7 cleavage of perlecan/HSPG2 complexed with
semaphorin 3A supports FAK-mediated stromal invasion by prostate
cancer cells. Sci Rep. 8:72622018. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kazanskaya GM, Tsidulko AY, Volkov AM,
Kiselev RS, Suhovskih AV, Kobozev VV, Gaytan AS, Aidagulova SV,
Krivoshapkin AL and Grigorieva EV: Heparan sulfate accumulation and
perlecan/HSPG2 up-regulation in tumour tissue predict low
relapse-free survival for patients with glioblastoma. Histochem
Cell Biol. 149:235–244. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhou X, Liang S, Zhan Q, Yang L, Chi J and
Wang L: HSPG2 overexpression independently predicts poor survival
in patients with acute myeloid leukemia. Cell Death Dis.
11:4922020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Li L, Meng X, Liu L, Xiang Y, Wang F, Yu
L, Zhou F, Zheng C, Zhou W, Cui S, et al: Single-nucleotide
polymorphisms in LEP and LEPR associated with breast cancer risk:
Results from a multicenter case-control study in Chinese females.
Front Oncol. 12:8095702022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Li B, He Y, Li P and Chen X: Leptin
receptor overlapping transcript (LEPROT) is associated with the
tumor microenvironment and a prognostic predictor in pan-cancer.
Front Genet. 12:7494352021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Hashemi Goradel N, Najafi M, Salehi E,
Farhood B and Mortezaee K: Cyclooxygenase-2 in cancer: A review. J
Cell Physiol. 234:5683–5699. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Jung YS, Stratton SA, Lee SH, Kim MJ, Jun
S, Zhang J, Zheng B, Cervantes CL, Cha JH, Barton MC and Park JI:
TMEM9-v-ATPase activates Wnt/β-catenin signaling via APC lysosomal
degradation for liver regeneration and tumorigenesis. Hepatology.
73:776–794. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zhang H, Wang Y and Ding H: COL4A1,
negatively regulated by XPD and miR-29a-3p, promotes cell
proliferation, migration, invasion and epithelial-mesenchymal
transition in liver cancer cells. Clin Transl Oncol. 23:2078–2089.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Mao K, You C, Lei D and Zhang H: Potential
regulation of glioma through the induction of apoptosis signaling
via Egl-9 family hypoxia-inducible factor 3. Oncol Lett.
13:893–897. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wang Y, Lieberman R, Pan J, Zhang Q, Du M,
Zhang P, Nevalainen M, Kohli M, Shenoy NK, Meng H, et al: miR-375
induces docetaxel resistance in prostate cancer by targeting SEC23A
and YAP1. Mol Cancer. 15:702016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Lassalle S, Zangari J, Popa A, Ilie M,
Hofman V, Long E, Patey M, Tissier F, Belléannée G, Trouette H, et
al: MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of
vandetanib. Oncotarget. 7:30461304782016. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Chen XL, Lei L, Hong LL and Ling ZQ:
Potential role of NDRG2 in reprogramming cancer metabolism and
epithelial-to-mesenchymal transition. Histol Histopathol.
33:655–663. 2018.PubMed/NCBI
|
|
90
|
Silini A, Ghilardi C, Figini S, Sangalli
F, Fruscio R, Dahse R, Pedley RB, Giavazzi R and Bani M: Regulator
of G-protein signaling 5 (RGS5) protein: A novel marker of cancer
vasculature elicited and sustained by the tumor's proangiogenic
microenvironment. Cell Mol Life Sci. 69:1167–1178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhou Z, Zhou Q, Wu X, Xu S, Hu X, Tao X,
Li B, Peng J, Li D, Shen L, et al: VCAM-1 secreted from
cancer-associated fibroblasts enhances the growth and invasion of
lung cancer cells through AKT and MAPK signaling. Cancer Lett.
473:62–73. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Ding K, Wu Z, Li X, Sheng Y, Wang X and
Tan S: LMO4 mediates trastuzumab resistance in HER2 positive breast
cancer cells. Am J Cancer Res. 8:594–609. 2018.PubMed/NCBI
|
|
93
|
Chen T, Chen X, Zhang S, Zhu J, Tang B,
Wang A, Dong L, Zhang Z, Yu C, Sun Y, et al: The genome sequence
archive family: toward explosive data growth and diverse data
types. Genomics Proteomics Bioinformatics. 19:578–583. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
CNCB-NGDC Members, . Partners Database
resources of the national genomics data center, China national
center for bioinformation in 2022. Nucleic Acids Res. 50(D1):
D27–D38. 2022. View Article : Google Scholar : PubMed/NCBI
|
